An economic evaluation of a specialist preventive care clinician in a community mental health service: a randomised controlled trial.
Chronic disease
Community mental health
Cost-effectiveness
Mental illness
Preventive care
Risk behaviours
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
11 May 2020
11 May 2020
Historique:
received:
17
10
2019
accepted:
12
04
2020
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
26
11
2020
Statut:
epublish
Résumé
Clinical practice guidelines and policies direct community mental health services to provide preventive care to address chronic disease risks, however, such care is infrequently provided in routine consultations. An alternative model of care is to appoint a clinician to the dedicated role of offering and providing preventive care in an additional consultation: the 'specialist clinician' model. Economic evaluations of models of care are needed to determine the cost of adhering to guidelines and policies, and to inform pragmatic service delivery decisions. This study is an economic evaluation of the specialist clinician model; designed to achieve policy concordant preventive care delivery. A retrospective analysis of the incremental costs, cost-effectiveness, and budget impact of a 'specialist preventive care clinician' (an occupational therapist) was conducted in a randomised controlled trial, where participants were randomised to receive usual care; or usual care plus the offer of an additional preventive care consultation with the specialist clinician. The study outcome was client acceptance of referrals to two free telephone-based chronic disease prevention services. This is a key care delivery outcome mandated by the local health district policy of the service. The base case analysis assumed the mental health service cost perspective. A budget impact analysis determined the annual budget required to implement the model of care for all clients of the community mental health service over 5 years. There was a significantly greater increase from baseline to follow-up in the proportion of intervention participants accepting referrals to both telephone services, compared to usual care. The incremental cost-effectiveness ratio was $347 per additional acceptance of a referral (CI: $263-$494). The annual budget required to implement the model of care for all prospective clients was projected to be $711,446 over 5-years; resulting in 2616 accepted referrals. The evaluation provides key information regarding the costs for the mental health service to adhere to policy targets, indicating the model of care involved a low per client cost whilst increasing key preventive care delivery outcomes. Additional modelling is required to further explore its economic benefits. ACTRN12616001519448. Registered 3 November 2016, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371709.
Sections du résumé
BACKGROUND
BACKGROUND
Clinical practice guidelines and policies direct community mental health services to provide preventive care to address chronic disease risks, however, such care is infrequently provided in routine consultations. An alternative model of care is to appoint a clinician to the dedicated role of offering and providing preventive care in an additional consultation: the 'specialist clinician' model. Economic evaluations of models of care are needed to determine the cost of adhering to guidelines and policies, and to inform pragmatic service delivery decisions. This study is an economic evaluation of the specialist clinician model; designed to achieve policy concordant preventive care delivery.
METHODS
METHODS
A retrospective analysis of the incremental costs, cost-effectiveness, and budget impact of a 'specialist preventive care clinician' (an occupational therapist) was conducted in a randomised controlled trial, where participants were randomised to receive usual care; or usual care plus the offer of an additional preventive care consultation with the specialist clinician. The study outcome was client acceptance of referrals to two free telephone-based chronic disease prevention services. This is a key care delivery outcome mandated by the local health district policy of the service. The base case analysis assumed the mental health service cost perspective. A budget impact analysis determined the annual budget required to implement the model of care for all clients of the community mental health service over 5 years.
RESULTS
RESULTS
There was a significantly greater increase from baseline to follow-up in the proportion of intervention participants accepting referrals to both telephone services, compared to usual care. The incremental cost-effectiveness ratio was $347 per additional acceptance of a referral (CI: $263-$494). The annual budget required to implement the model of care for all prospective clients was projected to be $711,446 over 5-years; resulting in 2616 accepted referrals.
CONCLUSIONS
CONCLUSIONS
The evaluation provides key information regarding the costs for the mental health service to adhere to policy targets, indicating the model of care involved a low per client cost whilst increasing key preventive care delivery outcomes. Additional modelling is required to further explore its economic benefits.
TRIAL REGISTRATION
BACKGROUND
ACTRN12616001519448. Registered 3 November 2016, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371709.
Identifiants
pubmed: 32393307
doi: 10.1186/s12913-020-05204-7
pii: 10.1186/s12913-020-05204-7
pmc: PMC7212584
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
405Subventions
Organisme : The Australian Prevention Partnership Centre
ID : through the NHMRC partnership centre grant scheme (Grant ID: GNT9100001)
Références
Addiction. 2005 Apr;100 Suppl 2:70-83
pubmed: 15844290
Psychiatr Serv. 2015 Aug 1;66(8):857-64
pubmed: 25930044
Clin Obes. 2014 Feb;4(1):39-44
pubmed: 25425131
Nicotine Tob Res. 2005 Apr;7 Suppl 1:S67-9
pubmed: 16036272
Eur J Obstet Gynecol Reprod Biol. 2007 Feb;130(2):262-70
pubmed: 16530916
Schizophr Res. 2016 Oct;176(2-3):431-440
pubmed: 27261419
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624
Tob Control. 2007 Aug;16(4):285-8
pubmed: 17652247
Tob Control. 2003 Sep;12 Suppl 2:ii53-8
pubmed: 12878774
Am J Lifestyle Med. 2011 May;5(3):
pubmed: 24358034
Aust N Z J Psychiatry. 2016 May;50(5):410-72
pubmed: 27106681
Am J Psychiatry. 2011 Nov;168(11):1171-8
pubmed: 21676993
Implement Sci. 2009 Jul 03;4:37
pubmed: 19575790
Aust N Z J Psychiatry. 2001 Apr;35(2):196-202
pubmed: 11284901
Lancet Psychiatry. 2019 Aug;6(8):675-712
pubmed: 31324560
Br J Psychiatry. 2009 Nov;195(5):448-56
pubmed: 19880936
Transl Behav Med. 2011 Sep 1;1(3):427-435
pubmed: 22081776
Community Ment Health J. 2016 Aug;52(6):667-74
pubmed: 27137507
World Psychiatry. 2011 Feb;10(1):52-77
pubmed: 21379357
J Clin Nurs. 2014 Apr;23(7-8):1018-29
pubmed: 24606393
BMC Psychiatry. 2014 Sep 02;14:234
pubmed: 25196125
Patient Educ Couns. 2009 Nov;77(2):289-95
pubmed: 19398293
Pharmacoeconomics. 2018 Jan;36(1):79-90
pubmed: 28905279
Am J Psychiatry. 2003 Dec;160(12):2228-30
pubmed: 14638595
Oncol Nurs Forum. 2000 Jul;27(6):923-32
pubmed: 10920832
J Adv Nurs. 2013 Jul;69(7):1539-48
pubmed: 22973945
JAMA. 2005 Jul 27;294(4):482-7
pubmed: 16046655
BMJ. 2013 May 21;346:f2539
pubmed: 23694688
Fam Med. 2011 Mar;43(3):179-84
pubmed: 21380950
JAMA Intern Med. 2015 Sep;175(9):1509-16
pubmed: 26076313
Aust N Z J Psychiatry. 2012 Aug;46(8):735-52
pubmed: 22696547
Aust N Z J Psychiatry. 2020 Jun;54(6):620-632
pubmed: 32403938
Can Fam Physician. 2013 Jan;59(1):27-31
pubmed: 23341653
Prev Med Rep. 2019 Aug 14;16:100969
pubmed: 31497500
Am J Prev Med. 2014 Dec;47(6):762-70
pubmed: 25455118
Psychosomatics. 2013 Jul-Aug;54(4):328-35
pubmed: 23274008
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
Am J Psychiatry. 2010 Feb;167(2):151-9
pubmed: 20008945
J Am Coll Cardiol. 2008 Dec 16;52(25):2119-26
pubmed: 19095128
Am J Prev Med. 2004 Aug;27(2 Suppl):88-101
pubmed: 15275677
Acta Psychiatr Scand. 2006 Oct;114(4):242-8
pubmed: 16968361
J Gen Intern Med. 2009 Feb;24(2):149-54
pubmed: 19083066
BJOG. 2013 May;120(6):765-70
pubmed: 23565948
Implement Sci. 2016 Apr 02;11:46
pubmed: 27039077
Am J Prev Med. 2004 Aug;27(2 Suppl):61-79
pubmed: 15275675
BMC Public Health. 2013 Aug 29;13:787
pubmed: 23988266
Value Health. 2014 Jan-Feb;17(1):5-14
pubmed: 24438712
Issues Ment Health Nurs. 2013 Mar;34(3):198-207
pubmed: 23477441
Trials. 2017 Jun 15;18(1):276
pubmed: 28619025
Synth Proj Res Synth Rep. 2011 Feb;(21):1-26
pubmed: 21675009
Int J Ment Health Nurs. 2013 Oct;22(5):409-17
pubmed: 23066812
Aust N Z J Psychiatry. 2015 Aug;49(8):731-41
pubmed: 25698807
Implement Sci. 2014 Dec 18;9:168
pubmed: 25518730
BMC Health Serv Res. 2010 Mar 10;10:61
pubmed: 20219096
Community Ment Health J. 2011 Jun;47(3):243-51
pubmed: 20419349